Skip to content
Screener

Embecta Corp. EMBC Total Revenue

Total Revenue at other companies

Insulet logo
InsuletPODD
$801.7M+23.5%
Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
$254.56M+5.8%
Medtronic logo
MedtronicMDT
$9.81B+9.9%
KORU Medical Systems logo
KORU Medical SystemsKRMD
$12.05M+18.2%
InfuSystem Holdings logo
InfuSystem HoldingsINFU
$33.68M-3.0%
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
$34.17M

Segments

By product

See full
Pen Needles$177.5M-18.2%
Safety$36.7M+5.5%
Syringes$36.6M+4.3%
Contract Manufacturing$5.3M-3.6%

By geography

See full
United States$160.2M

Other financials

Income statement

See full
Gross profit$153.3M-22.2%
Operating income$48.7M-48.2%
Net income$21.1M-53.6%
EPS (diluted)$0.36-53.8%

Balance sheet

See full
Cash & equivalents$218.2M-6.6%
Total debt$1.5B-1.0%
Total equity-$612.7M+8.5%
Total assets$1.3B+9.3%

Cash flow

See full
Operating cash flow$41.8M-48.5%
CapEx$1.1M+175%
Free cash flow$40.7M-49.6%

Valuation

See full
Market cap$281.03M-67.1%
Enterprise value$1.56B-26.8%
P/E3.2×-7.0×
P/S0.3×-0.5×

Profitability

See full
Gross margin59%-3.7pp
Operating margin21.9%+2.7pp
Net margin8.6%+1.0pp
FCF margin16.2%+4.2pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Embecta Corp.’s 10-Q, filed August 7, 2026.

Filed
Aug 7, 2026, 2:28 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q2 2026
Accession
0001872789-26-000033
Line itemThree Months Ended June 30, 2026Three Months Ended June 30, 2025Nine Months Ended June 30, 2026Nine Months Ended June 30, 2025
Revenues$271.7$295.5$754.7$816.4
Cost of products sold118.498.4311.9298.1
Gross Profit$153.3$197.1$442.8$518.3
Operating expenses:
Selling and administrative expense78.684.4232.4245.1
Research and development expense5.64.415.632.7
Other operating expense, net20.414.327.854.9
Total Operating Expenses$104.6$103.1$275.8$332.7

Item 1. Financial Statements (Unaudited)

FAQ

What is Embecta Corp.'s total revenue?
Embecta Corp. (EMBC) reported total revenue of $271.7M in Q2 2026.
How has Embecta Corp.'s total revenue changed year-over-year?
Embecta Corp.'s total revenue decreased by 8.1% year-over-year, from $295.5M to $271.7M.
What is the long-term trend for Embecta Corp.'s total revenue?
Over 4 years (2021 to 2025), Embecta Corp.'s total revenue has grown at a -1.9% compound annual growth rate (CAGR), from $1.17B to $1.08B.
What does total revenue mean?
The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Ask your AI about Embecta Corp.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude